Antimicrobial resistance dynamics and the one-health strategy: a review

One Health and the Politics of Antimicrobial Resistance

T use of antimicrobial drugs in food-producing animals can result in antimicrobial drug–resistant infections in humans. A good example is the use of fluoroquinolone in poultry and the emergence of fluoroquinolone-resistant Campylobacter infections among humans. However, topics of intense debate include the widespread use of antimicrobial drugs in animals, the extent to which antimicrobial drug ...

CIPARS: A One-Health Approach to Antimicrobial Resistance Surveillance

1Laboratory for Foodborne Zoonoses, Public Health Agency of Canada, Guelph, ON, Canada; 2Laboratory for Foodborne Zoonoses, Public Health Agency of Canada, St Hyacinthe, QC, Canada; 3Centre for Foodborne, Environmental, and Zoonotic Infectious Diseases, Public Health Agency of Canada, Guelph, ON, Canada; 4Laboratory for Foodborne Zoonoses, Public Health Agency of Canada, Saskatoon, SK, Canada; ...

One Health: Antimicrobial resistance and disease control: making One Health work.

Antimicrobial resistance and infectious disease control were the main themes at a One Health conference held in London last month. Hosted collaboratively by the Royal Society of Medicine and the Bella Moss Foundation, the meeting put particular emphasis on making the One Health concept work when dealing with resistance and disease control. Georgina Mills reports.

Strategy for antimicrobial resistance surveillance in Australia.

The importance of surveillance* in combating and managing antimicrobial† resistance (AMR) is recognised as an important component of the World Health Organization (WHO) Global Strategy for Containment of Antimicrobial Resistance, 2001. There is good evidence that surveillance is a costeffective infection control strategy.1,2 Appropriate surveillance provides vital information for the targeting ...

The new UK antimicrobial resistance strategy and action plan.